1. Home
  2. GCTK vs CELZ Comparison

GCTK vs CELZ Comparison

Compare GCTK & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GCTK
  • CELZ
  • Stock Information
  • Founded
  • GCTK 2001
  • CELZ 1998
  • Country
  • GCTK United States
  • CELZ United States
  • Employees
  • GCTK N/A
  • CELZ N/A
  • Industry
  • GCTK Medical/Dental Instruments
  • CELZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • GCTK Health Care
  • CELZ Health Care
  • Exchange
  • GCTK Nasdaq
  • CELZ Nasdaq
  • Market Cap
  • GCTK 5.1M
  • CELZ 4.4M
  • IPO Year
  • GCTK N/A
  • CELZ N/A
  • Fundamental
  • Price
  • GCTK $0.37
  • CELZ $5.40
  • Analyst Decision
  • GCTK
  • CELZ
  • Analyst Count
  • GCTK 0
  • CELZ 0
  • Target Price
  • GCTK N/A
  • CELZ N/A
  • AVG Volume (30 Days)
  • GCTK 4.1M
  • CELZ 139.9K
  • Earning Date
  • GCTK 03-27-2025
  • CELZ 03-21-2025
  • Dividend Yield
  • GCTK N/A
  • CELZ N/A
  • EPS Growth
  • GCTK N/A
  • CELZ N/A
  • EPS
  • GCTK N/A
  • CELZ N/A
  • Revenue
  • GCTK N/A
  • CELZ $11,000.00
  • Revenue This Year
  • GCTK N/A
  • CELZ N/A
  • Revenue Next Year
  • GCTK N/A
  • CELZ N/A
  • P/E Ratio
  • GCTK N/A
  • CELZ N/A
  • Revenue Growth
  • GCTK N/A
  • CELZ N/A
  • 52 Week Low
  • GCTK $0.36
  • CELZ $1.96
  • 52 Week High
  • GCTK $99.00
  • CELZ $10.28
  • Technical
  • Relative Strength Index (RSI)
  • GCTK 26.08
  • CELZ 69.61
  • Support Level
  • GCTK $0.49
  • CELZ $4.50
  • Resistance Level
  • GCTK $0.68
  • CELZ $6.90
  • Average True Range (ATR)
  • GCTK 0.20
  • CELZ 0.76
  • MACD
  • GCTK 0.17
  • CELZ 0.19
  • Stochastic Oscillator
  • GCTK 0.71
  • CELZ 60.53

About GCTK GlucoTrack Inc.

GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.

About CELZ Creative Medical Technology Holdings Inc.

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

Share on Social Networks: